BAY 1000394 25mg 25mg | Purity Not Available
Adooq Bioscience
BAY 1000394 is an orally bioavailable cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity.
More Information Supplier PageBAY 1000394 is an orally bioavailable cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity.
More Information Supplier PageBAY 1000394 is an orally bioavailable cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageDbeq is a selective and reversible inhibitor of p97 ATPase (IC50 = 1.5 uM).
More Information Supplier PageDbeq is a selective and reversible inhibitor of p97 ATPase (IC50 = 1.5 uM).
More Information Supplier PageDbeq is a selective and reversible inhibitor of p97 ATPase (IC50 = 1.5 uM).
More Information Supplier PageDbeq is a selective and reversible inhibitor of p97 ATPase (IC50 = 1.5 uM).
More Information Supplier PageDbeq is a selective and reversible inhibitor of p97 ATPase (IC50 = 1.5 uM).
More Information Supplier PageEPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.
More Information Supplier Page